BIOMAKERS

Recoleta, Argentina

BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.

$8.0M raised

Jan 2026

Series A

Top Investors

Oncology VenturesEndurance28Sonen CapitalAcumen LatAm Impact VenturesLabCorp Venture Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BIOMAKERS raised?

BIOMAKERS has raised $8.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.

Who are BIOMAKERS's investors?

BIOMAKERS's investors include Oncology Ventures, Endurance28, Sonen Capital, Acumen LatAm Impact Ventures, LabCorp Venture Fund.

Where is BIOMAKERS headquartered?

BIOMAKERS is headquartered in Recoleta, Argentina.

What does BIOMAKERS do?

BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.

What stage is BIOMAKERS at?

BIOMAKERS is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 12, 2026.

MLA

"BIOMAKERS — Funding & Investors." VCBacked, January 12, 2026, https://www.vcbacked.co/company/biomakers. Accessed June 3, 2026.

APA

VCBacked. (2026). BIOMAKERS — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/biomakers

Wikipedia (cite web)

{{cite web |title=BIOMAKERS — Funding & Investors |url=https://www.vcbacked.co/company/biomakers |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 12, 2026.